






AppraiseItNow provides certified appraisals for prescription drug inventory held by pharmacies, healthcare distributors, medical practices, and other licensed entities. These appraisals are most commonly needed for insurance claims following theft, fire, or contamination events, bankruptcy filings, estate settlements involving pharmacy businesses, IRS charitable donation reporting under Form 8283, and asset-based lending where drug inventory serves as collateral. Prescription drug appraisals require specialized knowledge of pharmaceutical pricing databases, expiration-sensitive valuation, regulatory constraints on transferability, and controlled substance classifications, all of which our appraisers are equipped to address. Our mission is to deliver defensible, USPAP-compliant valuations with exceptional speed, professionalism, and client service.
AppraiseItNow serves licensed pharmacies, compounding facilities, wholesale distributors, healthcare systems, bankruptcy trustees, estate attorneys, and CPAs who require independent valuations of pharmaceutical inventory. As a specialized subset of professional machinery and equipment valuations, prescription drug appraisals are typically completed remotely using inventory records, acquisition invoices, and current pharmaceutical pricing data, though onsite inspection may be coordinated when physical verification of stock, storage conditions, or controlled substance counts is required by the engagement scope. We offer Fair Market Value (FMV), Orderly Liquidation Value (OLV), Forced Liquidation Value (FLV), and Replacement Value appraisals for various intended uses.
Prescription drug appraisals cover a wide range of pharmaceutical inventory categories. The specific drug type, regulatory classification, and market availability each affect how value is determined.
AppraiseItNow serves licensed pharmacists, pharmacy owners, healthcare attorneys, bankruptcy trustees, CPAs, and insurance professionals who require credible, defensible valuations of prescription drug inventory. We also assist individual estate representatives and business owners navigating insurance claims, asset sales, or regulatory compliance situations involving pharmaceutical assets.
AppraiseItNow serves major businesses and commercial clients, including:
AppraiseItNow also serves individual consumers with projects large and small. These clients often include:
Given the USPAP-compliant nature of AppraiseItNow’s appraisal reports, we prepare our deliverables for major legal, tax, and financial reporting purposes for individual and commercial clients.
Popular uses of our appraisal reports include:
AppraiseItNow appraises a wide range of prescription drug inventory, including retail pharmacy stock, hospital and clinical formulary supplies, specialty biologics, controlled substances, and bulk pharmaceutical lots. We handle both individual items and large collections across all drug categories, including Schedule II through V controlled substances, insulin and cold-chain medications, and branded or generic formulations. Whether the drugs are sealed in original blister packs, bulk bottles, or unit-dose packaging, our appraisers can assess their value for a variety of purposes.
Yes. All AppraiseItNow prescription drug appraisals are developed and reported in compliance with USPAP Standards 7 and 8, which govern personal property appraisal development and reporting. Our reports meet the IRS definition of a qualified appraisal, making them suitable for charitable donation filings, estate tax returns, insurance claims, and litigation. Where extraordinary assumptions are required, such as assuming proper storage conditions when logs are unavailable, those assumptions are clearly disclosed in the report.
There are several situations that call for a professional prescription drug appraisal:
Yes, though condition and documentation significantly affect value and the scope of work required. Appraisers assess physical indicators of degradation such as color changes, odor, and packaging integrity, and cross-reference lot numbers against the FDA National Drug Code Directory to verify authenticity. When storage logs are missing or incomplete, appraisers may apply hypothetical conditions or conservative depreciation schedules, and any such assumptions are disclosed in the report per USPAP requirements.
Yes. AppraiseItNow regularly appraises large pharmaceutical inventories, including full pharmacy stock, hospital formulary collections, and multi-location drug lots. For larger engagements, we coordinate onsite inspections to physically verify packaging seals, lot traceability, and storage conditions. Volume pricing is available for collections of ten or more items, and our team can scale the engagement to match the complexity of the inventory.
Most prescription drug appraisals are completed remotely using photographs, inventory records, NDC codes, and storage documentation submitted by the client. For larger projects, complex controlled substance collections, or situations requiring physical inspection of packaging and condition, we can coordinate an in-person appraiser anywhere in the United States. Remote appraisals are fast and convenient for straightforward lots, while onsite inspections ensure thoroughness for high-value or high-complexity engagements.
Appraisal fees depend on the scope, purpose, and size of the engagement. Standard appraisals for insurance coverage, internal planning, estate distribution, and probate start at $295. Advanced appraisals for IRS filings, charitable contributions on Form 8283, M&A due diligence, asset-based lending, litigation support, bankruptcy, and transactional uses start at $395. Typical fee ranges by volume are:
Yes. Volume pricing is available for larger pharmaceutical inventories, and the per-item cost generally decreases as the size of the collection increases. Engagements covering 50 or more items are priced starting at $5,000 and are frequently conducted onsite to ensure accuracy. Contact AppraiseItNow directly to receive a fixed-price quote tailored to your specific inventory size and appraisal purpose.
Most remote prescription drug appraisals are completed within 7 to 10 business days from the time all required documentation is received. Onsite inspections or larger pharmaceutical collections typically take 2 to 3 weeks. Rush service is available for same-day or next-day turnaround upon request, which is useful for time-sensitive insurance claims, legal proceedings, or donation deadlines.
Appraisal reports are prepared by credentialed appraisers with expertise in personal property and pharmaceutical assets. Each report is reviewed for USPAP compliance and accuracy before delivery. AppraiseItNow's team includes appraisers with designations from recognized credentialing bodies and experience handling regulated assets including controlled substances and specialty pharmaceuticals.
Yes. AppraiseItNow works with appraisers holding credentials from recognized professional organizations including the American Society of Appraisers (ASA) in the personal property discipline, the International Society of Appraisers (ISA), and the Appraisers Association of America (AAA). These credentials require demonstrated education, examination, and adherence to USPAP standards, which is especially important for IRS-qualified appraisals of pharmaceutical assets.
Yes. When prescription drugs are donated to qualifying organizations and the claimed value exceeds $5,000, IRS rules require a qualified appraisal attached to Form 8283 Section B. AppraiseItNow prepares appraisals that meet all IRS requirements for qualified appraisals, including appraiser independence, proper methodology, and USPAP compliance. If the donee organization sells or disposes of the drugs within three years, IRS Form 8282 reporting requirements may also apply.
Yes. When a decedent's estate includes prescription drug inventory, such as a pharmacy business or a large personal supply, those assets must be valued for the estate tax return on Form 706. AppraiseItNow provides fair market value appraisals that meet IRS standards for estate tax reporting. The 2025 federal estate tax exemption threshold is $13.61 million, and detailed valuations of non-cash assets like pharmaceutical inventory are required when the gross estate approaches or exceeds that amount.
No. AppraiseItNow is an independent appraisal firm and does not buy, sell, or broker prescription drugs or pharmaceutical inventory. Our role is strictly to provide objective, unbiased valuations. Maintaining independence from any transaction is a core USPAP requirement and is essential for our appraisals to be accepted by the IRS, insurers, and courts.
To begin a prescription drug appraisal, it helps to have the following available:
Yes. Remote appraisals are available nationwide and can be completed using documentation, photographs, and inventory records submitted electronically. For larger pharmaceutical inventories, complex controlled substance collections, or situations requiring physical inspection, we can coordinate an in-person appraiser in any state. There is no geographic limitation on our services.
AppraiseItNow appraisals are USPAP-compliant, prepared by qualified appraisers, and structured to meet the specific requirements of the intended use. For IRS purposes, our reports satisfy the definition of a qualified appraisal under Treasury Regulation 1.170A-17. For insurance claims and litigation, our reports provide the documented methodology, data sources, and credentialed sign-off that adjusters and courts require. Acceptance ultimately depends on the facts of each case, but our reports are built to withstand scrutiny.
Controlled substances present unique regulatory considerations that affect both the appraisal process and the resulting value. DEA Schedule II drugs such as oxycodone require DEA Form 222 for any transfer, and appraisers must account for these transfer restrictions when determining fair market value, since the pool of eligible buyers is legally limited. AppraiseItNow works with appraisers who understand DEA licensing requirements and can produce reports that reflect the restricted-use nature of these assets without overstating value in a way that would invite IRS challenge.
Cold-chain integrity is one of the most consequential value factors for medications like insulin, which must be stored continuously between 2 and 8 degrees Celsius. If validated temperature logs from the shipper or storage facility are unavailable, appraisers may depreciate the value of these drugs by 70 to 100 percent even if the expiration date has not passed, because degradation cannot be ruled out. Clients seeking appraisals for cold-chain medications should gather all available shipper logs, refrigeration records, and chain-of-custody documentation before the appraisal begins.
If a donee organization sells, exchanges, or otherwise disposes of donated prescription drugs within three years of the donation date, it is generally required to file IRS Form 8282 and notify the original donor. This can trigger IRS scrutiny of the original charitable deduction, particularly if the organization's disposal price differs significantly from the appraised value used on Form 8283. Having a well-documented, defensible appraisal from the time of donation is the best protection against a subsequent IRS challenge to the deduction amount.




